Paper - WANFANG MED ONLINE

You Position: Home > Paper

Loss of GRB2 associated binding protein 1 in arteriosclerosis obliterans promotes host autophagy

( views:49, downloads:16 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 1

DOI:: 10.1097/CM9.0000000000001255

Key Word:: Arteriosclerosis obliterans;Autophagy;GRB2 associated binding protein 1;JNK pathway;p38 kinase pathway;Arteriosclerosis obliterans;Autophagy;GRB2 associated binding protein 1;JNK pathway;p38 kinase pathway

Abstract： Background::Arteriosclerosis obliterans (ASO) is a major cause of adult limb loss worldwide. Autophagy of vascular endothelial cell (VEC) contributes to the ASO progression. However, the molecular mechanism that controls VEC autophagy remains unclear. In this study, we aimed to explore the role of the GRB2 associated binding protein 1 (GAB1) in regulating VEC autophagy.Methods::In vivo and in vitro studies were applied to determine the loss of adapt protein GAB1 in association with ASO progression. Histological GAB1 expression was measured in sclerotic vascular intima and normal vascular intima. Gain- and loss-of-function of GAB1 were applied in VEC to determine the effect and potential downstream signaling of GAB1. Results::The autophagy repressor p62 was significantly downregulated in ASO intima as compared to that in healthy donor (0.80 vs. 0.20, t= 6.43, P < 0.05). The expression level of GAB1 mRNA (1.00 vs. 0.24, t= 7.41, P < 0.05) and protein (0.72 vs. 0.21, t = 5.97, P < 0.05) was significantly decreased in ASO group as compared with the control group. Loss of GAB1 led to a remarkable decrease in LC3II (1.19 vs. 0.68, t = 5.99, P < 0.05), whereas overexpression of GAB1 significantly led to a decrease in LC3II level (0.41 vs. 0.93, t= 7.12, P < 0.05). Phosphorylation levels of JNK and p38 were significantly associated with gain- and loss-of-function of GAB1 protein. Conclusion::Loss of GAB1 promotes VEC autophagy which is associated with ASO. GAB1 and its downstream signaling might be potential therapeutic targets for ASO treatment.

Reference

[1]Jinglei Liu,Kun Zhao,Nunu Huang,etc.Circular RNAs and human glioma[J].2019,(1).
[2]Bo Lei,Zhiqiang Tian,Weiping Fan,etc.Circular RNA: a novel biomarker and therapeutic target for human cancers[J].2019,16(2).
[3]Hao, Zheng,Hu, Si,Liu, Zheng,etc.Circular RNAs: Functions and Prospects in Glioma[J].2019,67(1).
[4]Pengcheng Jin,Yuenuo Huang,Penglei Zhu,etc.CircRNA circHIPK3 serves as a prognostic marker to promote glioma progression by regulating miR-654/IGF2BP3 signaling[J].2018,503(3).
[5]Debarati,Ghosh,Saikat,Nandi,Sonali,Bhattacharjee.Combination therapy to checkmate Glioblastoma: clinical challenges and advances.[J].2018,7(1).
[6]Sebastian Memczak,Marvin Jens,Antigoni Elefsinioti,etc.Circular RNAs are a large class of animal RNAs with regulatory potency[J].2013,495(Mar.21 TN.7441).
[7]Zhou, Jinxu,Wang, Hongxiang,Chu, Junsheng,etc.Circular RNA hsa_circ_0008344 regulates glioblastoma cell proliferation, migration, invasion, and apoptosis[J].2018,32(7).
[8]Fenton T,Hahn WC,Ligon KL,etc.Malignant astrocytic glioma: genetics, biology, and paths to treatment.[J].2007,21(21).
[9]Mary Elizabeth,Davis.Glioblastoma: Overview of Disease and Treatment.[J].2016.
[10]Polivka, Jiri, Jr.,Polivka, Jiri,Holubec, Lubos,etc.Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme[J].2017,37(1).
[11]Strobel, Hannah,Baisch, Tim,Fitzel, Rahel,etc.Temozolomide and Other Alkylating Agents in Glioblastoma Therapy[J].2019,7(3).
[12]Haiyang,Xu,Yu,Zhang,Ling,Qi,etc.NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway.[J].2018,11.
[13]Xinxing Li,Hongyu Diao.Circular RNA circ_0001946 acts as a competing endogenous RNA to inhibit glioblastoma progression by modulating miR‐671‐5p and CDR1[J].2019,234(8 Pt.1).
[14]J,Xin,X-Y,Zhang,D-K,Sun,etc.Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.[J].2019,23(8).
[15]Lee, Eric Chun Shen,Elhassan, Safa Abdelgadir Mohamed,Lim, Grace Pei Ling,etc.The roles of circular RNAs in human development and diseases[J].2019,111.
[16]Cantrell, J. Nathan,Waddle, Mark R.,Rotman, Maarten,etc.Progress Toward Long-Term Survivors of Glioblastoma[J].2019,94(7).
[17]Liu, Jianhong,Li, Dongpei,Luo, Hui,etc.Circular RNAs: The star molecules in cancer[J].2019,70.
[18]Li, Jian,Hou, Jun-chen,Wang, Dan-dan,etc.Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer[J].2018,107.
[19]Yang, Yibing,Gao, Xinya,Zhang, Maolei,etc.Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis[J].2018,110(3).
[20]Phillip A. Sharp,Jeremy E. Wilusz.A Circuitous Route to Noncoding RNA[J].2013,340(Apr.26 TN.6131).
[21]Hemi, Malkki.Trial Watch: Glioblastoma vaccine therapy disappointment in Phase III trial.[J].2016.
[22]Amanda Shea,Varsha Harish,Zainab Afzal,etc.MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics[J].2016,5(8).
[23]Zhang,Y.,Zhang,X.-O.,Chen,T.,etc.Circular Intronic Long Noncoding RNAs[J].2013,51(6).
[24]Q-L, Bai,C-W, Hu,X-R, Wang,etc.MiR-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of SOX7 via the Wnt signaling pathway.[J].2017,21(24).
[25]Hansen Thomas B.,Jensen Trine I.,Clausen Bettina H.,etc.Natural RNA circles function as efficient microRNA sponges[J].2013,495(7441).
[26]Ebert Margaret S,Neilson Joel R,Sharp Phillip A.MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells[J].2007,4(9).
[27]Kristensen, L. S.,Hansen, T. B.,Veno, M. T.,etc.Circular RNAs in cancer: opportunities and challenges in the field[J].2018,37(5).
[28]Xin, Sheng,Huang, Kai,Zhu, Xin-Gen.Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation[J].2019,215(9).
[29]Alifieris, Constantinos,Trafalis, Dimitrios T..Glioblastoma multiforme: Pathogenesis and treatment[J].2015,152.
[30]Feng, Li,Ke, Ma,Meihua, Sun,etc.Identification of the tumor-suppressive function of circular RNA ITCH in glioma cells through sponging miR-214 and promoting linear ITCH expression.[J].2018,10(5).